In conclusion, our study elucidates the role of Clec7a in microglial synaptic phagocytosis in tau pathology, offering compelling evidence that targeting Clec7a could mitigate synaptic loss and neuroinflammation in tauopathies. The gene discussed is MAPT; the disease is tauopathy.